Marc S. Ernstoff

Oncology
1 Medical Center Dr
Lebanon, NH 03756

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications

Retroelement Hypomethylation Links Hypoxia Signaling, Immune Phenotypes, and Survival in Clear Cell Renal Cell Carcinoma.

Retroelement Hypomethylation Links Hypoxia Signaling, Immune Phenotypes, and Survival in Clear Cell Renal Cell Carcinoma.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

Chronic sequelae of immune-related adverse events.

Chronic sequelae of immune-related adverse events.

Journal: Expert opinion on drug safety
Published: February 23, 2026

Chronic sequelae of immune-related adverse events.

Chronic sequelae of immune-related adverse events.

Journal: Expert opinion on drug safety
Published: February 23, 2026

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Journal: Journal for immunotherapy of cancer
Published: February 10, 2026

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Journal: Journal for immunotherapy of cancer
Published: August 27, 2025

Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management.

Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management.

Journal: Frontiers in immunology
Published: August 03, 2025

Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers.

Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers.

Journal: Cancers
Published: June 18, 2025

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.

Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 03, 2025

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 29, 2024

Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal Samples.

Improving Accuracy of Somatic Mutation Profiling in Large Epidemiologic Studies: Addressing Cases without Matched Normal Samples.

Journal: bioRxiv : the preprint server for biology
Published: November 18, 2024

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Journal: JCO precision oncology
Published: November 07, 2024

Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).

Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).

Journal: Journal for immunotherapy of cancer
Published: October 11, 2024
Showing 1-12 of 140

Last Updated: 09/26/2026